4D Molecular Therapeutics Raises $105M in Series D

4D Molecular Therapeutics has successfully raised $105M in a Series D at a $800M valuation led by Versant Ventures, Foresite Capital, Viking Global Investors, Fidelity.

Company Overview

4D Molecular Therapeutics is a Biotech company headquartered in 5858 Horton Street, Emeryville, CA 94608, founded in 2013 with 200+ employees.

Targeted gene therapy vectors

Fundraising Details

• Amount Raised: $105M
• Round Type: Series D
• Valuation: $800M
• Date: 2024-05-27
• Investors: Versant Ventures, Foresite Capital, Viking Global Investors, Fidelity

About 4D Molecular Therapeutics

Targeted gene therapy vectors The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: 5858 Horton Street, Emeryville, CA 94608
• Founded: 2013
• Team Size: 200+
• Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in 4D Molecular Therapeutics's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. 4D Molecular Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $800M valuation marks an important milestone for 4D Molecular Therapeutics, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, 4D Molecular Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-05-27. For more information about 4D Molecular Therapeutics, visit their headquarters at 5858 Horton Street, Emeryville, CA 94608.